Hubei Biocause Pharmaceutical Co., Ltd.

Symbol: 000627.SZ

SHZ

3.18

CNY

company-market-status

  • 45.3631

    P/E ratio

  • -2.6084

    PEG ratio

  • 15.71B

    Mrk Cap

  • 0.03%

    Div Yield

Hubei Biocause Pharmaceutical Co., Ltd. (000627-SZ) Stock Split, History Data

Оборотен капитал

Всички числа в милиони

202220212020201920182017
Парични средства и инвестиции26309.3223250.3026857.1512991.6918317.5011172.14
Приемници0.000.000.000.000.000.00
Инвентарна книга10504.0210224.4610716.163671.563820.49569.38
Други0.00---27680.6011488.20
Общо текущи активи55977.5950358.4351743.0525785.0049818.5927394.50
Acc Payable206.9093.5135.01156.5183.51106.08
Краткосрочен дълг21189.589425.774583.826179.7535.50279.50
Други текущи пасиви3589.273540.573397.532097.5926028.979865.18
Текущи пасиви24985.7513059.858016.368433.8626486.4210269.95

Капиталова структура

Всички числа в милиони

Общо активи

299414,72 щ.д.

Общо активи

299414717614,08 щ.д.

Общо задължения

264151,66 щ.д.

Общо задължения

264151655752,38 щ.д.

Дългосрочен дълг

6894,01 щ.д.

Дългосрочен дълг

6894011967,92 щ.д.

Парични средства и екви

31777,13 щ.д.

Парични средства и екви

31777126584,59 щ.д.

Goodwill

6192,21 щ.д.

Goodwill

6192211156,66 щ.д.

Неразпределена печалба

6553,75 щ.д.

Неразпределена печалба

6553752046,70 щ.д.

Обикновени акции

594,79 щ.д.

Обикновени акции

594794933,00 щ.д.

Стойност на предприятието

0,00 щ.д.

Дивиденти за маса

Подзаглавие на таблицата Dividends

ГодиниQ1Q2Q3Q4Общо
19980.0000.0300.0000.0000.030
20010.0000.0100.0000.0000.010
20020.0000.0050.0000.0000.005
20080.0000.0000.0160.0000.016
20100.0000.0090.0000.0000.009
20160.0000.0100.0000.0000.010
20170.0000.0250.0000.0000.025
20180.0000.0100.0000.0300.040
20190.0000.0000.0300.0000.030
20200.0000.1000.0000.0000.100
20210.0000.0100.0000.0000.010
20220.0000.0050.0000.0000.005
20230.0000.1100.0000.0000.110

Печалба на акция

Подзаглавие "Доходи на акция

ГодиниQ1Q2Q3Q4Общо
19980.0000.0300.0000.0000.030
20010.0000.0100.0000.0000.010
20020.0000.0050.0000.0000.005
20080.0000.0000.0160.0000.016
20100.0000.0090.0000.0000.009
20160.0000.0100.0000.0000.010
20170.0000.0250.0000.0000.025
20180.0000.0100.0000.0300.040
20190.0000.0000.0300.0000.030
20200.0000.1000.0000.0000.100
20210.0000.0100.0000.0000.010
20220.0000.0050.0000.0000.005
20230.0000.1100.0000.0000.110
Подобни запаси
Може да се интересувате и от
2888.TW
Shin Kong Financial Holding Co., Ltd..
9.13 TWD
TAI
PUK
Prudential plc.
28.58 USD
NYSE
ICICIPRULI.NS
ICICI Prudential Life Insurance Company Limited.
496.7 INR
NSE
ELF.TO
E-L Financial Corporation Limited.
892.26 CAD
TSX
POW.TO
Power Corporation of Canada.
35.15 CAD
TSX
PNLF.JK
PT Panin Financial Tbk.
268 IDR
JKT
PWF-PZ.TO
Power Financial Corporation.
19.97 CAD
TSX
BHFAO
Brighthouse Financial, Inc..
24.2 USD
NASDAQ
0945.HK
Manulife Financial Corporation.
146.3 HKD
HKSE
088350.KS
Hanwha Life Insurance Co., Ltd..
2660 KRW
KSC
7181.T
Japan Post Insurance Co., Ltd..
2154 JPY
JPX

Frequently Asked Question

Why is your stock tool better than competitors?

Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms

Can I trust the data on your website and where do they come from?

Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.

Who creates the content on your website and is it approved by experts in finance and investing?

All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.

What problem does your tool solve? Who is the target audience for your tool

Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.

Why did you decide to create your tool?

While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.

What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?

Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee

Who is your team and do they have enough experience?

You can read about our team here, or you can contact us at [email protected] for more information.